Opportunity Information: Apply for CDC RFA IP16 1604
Apply for CDC RFA IP16 1604
- The HHS-CDC-NCIRD in the health sector is offering a public funding opportunity titled "Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on May 17, 2016 and posted on May 17, 2016.
- Applicants must submit their applications by Jul 18, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States" (Funding Opportunity Number CDC RFA IP16-1604) is a discretionary funding announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), specifically through NCIRD. It is structured as a cooperative agreement, meaning the CDC expects to play an active role beyond simply providing funds, typically through ongoing collaboration, technical support, and shared responsibility for program direction and deliverables. The overall intent is to help selected foreign governments take practical steps that lead to national policy decisions on seasonal influenza vaccination, and then to support the real-world rollout or expansion of national influenza vaccination programs.
The core purpose is twofold. First, it supports countries that are considering introducing seasonal influenza vaccine into their public health programs or expanding existing use, with an emphasis on generating the evidence, planning, and stakeholder alignment needed to reach policy decisions. Second, it supports implementation activities once a country is ready to act, helping translate policy into an operational vaccination program. In practice, this kind of opportunity typically focuses on strengthening country capacity to plan and deliver influenza vaccination: establishing or refining national strategies, defining priority groups, integrating influenza vaccination into routine immunization or adult vaccination platforms, and addressing programmatic needs such as procurement planning, cold chain and logistics, workforce training, risk communication, and monitoring and evaluation. Because the announcement explicitly mentions "support and technical assistance," it signals that recipients can expect CDC engagement around best practices, program design, and use of surveillance and burden data to guide decisions.
The funding instrument and scale provide additional context about what CDC intended to support. With an award ceiling of $250,000 and an expectation of about five awards, the announcement appears designed for targeted, time-bound capacity-building and planning efforts rather than large-scale vaccine purchase. Funds at this level are often used to support coordination, technical work, demonstration activities, training, policy workshops, microplanning, development of guidelines, strengthening data systems, and evaluation, rather than covering the full cost of vaccine supply for a nationwide campaign. The activity category is health, and the CFDA number listed is 93.318, which aligns it with CDC immunization and respiratory disease-related assistance frameworks.
Eligibility is summarized as "Others" with further clarification referenced in an additional eligibility field (not included in the excerpt). However, the description makes clear the intended beneficiaries are foreign governments outside the United States, framed here as the foreign governments of "X." That implies the program is oriented toward ministries of health or their designated national public health institutions, potentially including government-affiliated entities or partners working under government direction, depending on the detailed eligibility language in the full announcement.
Administratively, the opportunity was posted and created on May 17, 2016, with a closing date of July 18, 2016. Those dates indicate it was a specific funding cycle in 2016. The combination of the cooperative agreement model, a moderate per-award ceiling, and a small number of expected awards suggests CDC aimed to work closely with a limited set of countries to accelerate the decision-making and implementation process for seasonal influenza vaccination programs, likely emphasizing sustainable national systems, evidence-informed policy, and program readiness rather than one-time activities.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is CDC RFA IP16-1604.
Which agency is offering this funding?
This is a discretionary funding announcement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), specifically through NCIRD.
What type of funding instrument is this?
This opportunity is structured as a cooperative agreement, meaning CDC expects to play an active role beyond providing funds, typically through ongoing collaboration, technical support, and shared responsibility for program direction and deliverables.
What is the overall intent of the program?
The intent is to help selected foreign governments take practical steps that lead to national policy decisions on seasonal influenza vaccination, and then to support the real-world rollout or expansion of national influenza vaccination programs.
Who is the program intended to benefit?
Based on the description, the intended beneficiaries are foreign governments outside the United States, framed as foreign governments (for example, ministries of health or designated national public health institutions), subject to the detailed eligibility language in the full announcement.
Is this opportunity for U.S.-based programs?
No. The opportunity is explicitly focused on public health programs outside of the United States.
What are the two main purposes of the funding?
The purpose is twofold: (1) to support countries considering introducing seasonal influenza vaccine or expanding existing use by generating evidence, planning, and stakeholder alignment needed to reach policy decisions; and (2) to support implementation activities once a country is ready to act, helping translate policy into an operational vaccination program.
What kinds of activities does this funding typically support?
The description indicates a focus on strengthening country capacity to plan and deliver influenza vaccination. This typically includes establishing or refining national strategies, defining priority groups, integrating influenza vaccination into routine immunization or adult vaccination platforms, and addressing programmatic needs such as procurement planning, cold chain and logistics, workforce training, risk communication, and monitoring and evaluation.
Does the opportunity include technical assistance from CDC?
Yes. The announcement explicitly mentions "support and technical assistance," signaling that recipients can expect CDC engagement around best practices, program design, and use of surveillance and burden data to guide decisions.
How involved is CDC expected to be during the project?
Because this is a cooperative agreement, CDC is expected to have an active role, typically including ongoing collaboration, technical support, and shared responsibility for program direction and deliverables.
What is the award ceiling (maximum award amount)?
The award ceiling is $250,000.
How many awards were expected?
The announcement indicates an expectation of about five awards.
Is this funding intended to purchase large quantities of influenza vaccine?
Based on the award ceiling and the described intent, the funding appears designed for targeted, time-bound capacity-building and planning efforts rather than large-scale vaccine purchase.
What are examples of costs this funding is more likely to support?
At this funding level, the description suggests support for coordination, technical work, demonstration activities, training, policy workshops, microplanning, development of guidelines, strengthening data systems, and evaluation, rather than covering the full cost of vaccine supply for a nationwide campaign.
What is the activity category?
The activity category listed is health.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.318.
What does the eligibility category say?
Eligibility is summarized as "Others," with further clarification referenced in an additional eligibility field that is not included in the provided excerpt.
Based on the description, who is most likely eligible to apply?
While the excerpt does not include the detailed eligibility field, the description indicates the program is oriented toward foreign governments outside the United States, such as ministries of health or designated national public health institutions, and potentially government-affiliated entities or partners working under government direction depending on the full announcement.
When was the opportunity posted and created?
The opportunity was posted and created on May 17, 2016.
What was the closing date (deadline) for applications?
The closing date was July 18, 2016.
Is this opportunity tied to a specific funding cycle?
Yes. The posted/created date and closing date indicate it was a specific funding cycle in 2016.
What programmatic focus does CDC appear to emphasize in this opportunity?
The structure (cooperative agreement), moderate per-award ceiling, and small number of anticipated awards suggest CDC aimed to work closely with a limited set of countries to accelerate decision-making and implementation for seasonal influenza vaccination programs, emphasizing sustainable national systems, evidence-informed policy, and program readiness rather than one-time activities.
Browse more opportunities from the same agency: HHS-CDC-NCIRD
Browse more opportunities from the same category: Health
Next opportunity: Countering Violent Extremism
Previous opportunity: Urban Archeology Corps
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP16 1604
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP16 1604) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 16 269 Funding Number: PAR 16 269 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01) Apply for RFA AI 16 047 Funding Number: RFA AI 16 047 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) Apply for PAR 16 268 Funding Number: PAR 16 268 Agency: HHS-NIH11 Category: Health Funding Amount: $50,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 16 270 Funding Number: PAR 16 270 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 16 272 Funding Number: PAR 16 272 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) Apply for PAR 16 271 Funding Number: PAR 16 271 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Healthy Tomorrows Partnership for Children Program (HTPCP) Apply for HRSA 17 008 Funding Number: HRSA 17 008 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies (STD AAPPS) Apply for CDC RFA PS14 140204CONT17 Funding Number: CDC RFA PS14 140204CONT17 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| CDC’s National Undergraduate Student Program: A Public Health Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 110106CONT16 Funding Number: CDC RFA MN11 110106CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Fogarty Global Health Training Program (D43) Apply for RFA TW 16 002 Funding Number: RFA TW 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: $1,100,000 |
| Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus Apply for CDC RFA DD16 1605 Funding Number: CDC RFA DD16 1605 Agency: HHS-CDC-NCBDDD Category: Health Funding Amount: $360,000 |
| Developing New Clinical Decision Support to Disseminate and Implement Patient-Centered Outcomes Research Findings (R18) Apply for PA 16 282 Funding Number: PA 16 282 Agency: HHS-AHRQ Category: Health Funding Amount: $750,000 |
| Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Specialized Center Cooperative Agreements (U54) Apply for RFA OD 16 011 Funding Number: RFA OD 16 011 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Comprehensive Platform for Integrated Communication Initiative (CPICI) Apply for RFA 621 16 000003 Funding Number: RFA 621 16 000003 Agency: USAID-TAN Category: Health Funding Amount: $46,200,000 |
| Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Resource Cooperative Agreement (U42) Apply for RFA OD 16 012 Funding Number: RFA OD 16 012 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Patient-Centered Outcomes Research Findings (R18) Apply for PA 16 283 Funding Number: PA 16 283 Agency: HHS-AHRQ Category: Health Funding Amount: $500,000 |
| Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK12 120505CONT16 Funding Number: CDC RFA CK12 120505CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 15050203SUPP16 Funding Number: CDC RFA CK15 15050203SUPP16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Systems Approach to Immunity and Inflammation (U19) Apply for RFA AI 16 050 Funding Number: RFA AI 16 050 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention (UG3/UH3) Apply for RFA AI 16 031 Funding Number: RFA AI 16 031 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP16 1604", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.